Assignee
POLARX BIOPHARMACEUTICALS INC
US·5 granted patents·3 pending applications·35 citations·filing 1998–2004
Top patents by PatentIndex Score
8 records- 0179US6875451B2Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compoundsPOLARX BIOPHARMACEUTICALS INC·Filed 1998·Granted Apr 5, 2005·32 cites·11 claims
- 0263US7205001B2Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compoundsPOLARX BIOPHARMACEUTICALS INC·Filed 2003·Granted Apr 17, 2007·2 cites·14 claims
- 0360US7179493B2Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compoundsPOLARX BIOPHARMACEUTICALS INC·Filed 2003·Granted Feb 20, 2007·1 cites·9 claims
- 0455US7163703B2Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compoundsPOLARX BIOPHARMACEUTICALS INC·Filed 2003·Granted Jan 16, 2007·0 cites·10 claims
- 0555US7132116B2Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compoundsPOLARX BIOPHARMACEUTICALS INC·Filed 2003·Granted Nov 7, 2006·0 cites·11 claims
- 0655US2004197420A1Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compoundsPOLARX BIOPHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 0755US2004197421A1Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compoundsPOLARX BIOPHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 0851US2004161475A1Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compoundsPOLARX BIOPHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when POLARX BIOPHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →